NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT00290706 2019-05-28A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaNorthwestern UniversityPhase 1/2 Terminated32 enrolled 12 charts
NCT00324597 2013-09-17AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Unknown18 enrolled
NCT00019513 2012-03-23Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed108 enrolled